Selected Publication:
Neugebauer, E; Rixen, D; Raum, M; Schäfer, U.
Thirty years of anti-mediator treatment in sepsis and septic shock--what have we learned?
Langenbecks Arch Surg. 1998; 383(1):26-34
Doi: 10.1007/s004230050088
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Schäfer Ute
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Sepsis, the systemic response (specific and non-specific) of the body to an infection, is an increasing clinical problem. During the last 30 years, nearly 50 clinical trials involving more than 10,000 patients have failed to demonstrate improvement of patients' outcome with different "anti-mediator" strategies. The wrong conceptional approaches to interact with the complex mediator network and flaws in study design and conduct are the main reasons for this disappointing situation. We learned, however, that the systemic host response is more than persistent uncontrolled inflammation; it is also a stimulation of the counter regulatory network. Although it is important to analyse the complex picture, we have now reached a point where more sophisticated strategies for describing complexity and novel attempts for synthesis are needed. Along this line, improved study designs (decrease of "signal-to-noise ratio") are mandatory. In addition, secondary preventive strategies are emphasised.
- Find related publications in this database (using NLM MeSH Indexing)
-
Clinical Trials as Topic -
-
Humans -
-
Inflammation Mediators - antagonists and inhibitors
-
Research Design - antagonists and inhibitors
-
Shock, Septic - drug therapy
-
Systemic Inflammatory Response Syndrome - drug therapy
-
Treatment Outcome - drug therapy
- Find related publications in this database (Keywords)
-
sepsis
-
mediators
-
antimediators
-
modulation
-
study design
-
complexity